Clinical trial suggests convalescent plasma may improve survival with severe COVID-19
Stair climbing offers significant cardiovascular and muscular benefits for heart patients
17 May 2021New study of how US recreational cannabis legalization could change illegal drug markets
17 May 2021Clinical trial suggests convalescent plasma may improve survival with severe COVID-19
A randomized double-blind controlled trial of convalescent plasma for adults hospitalized with severe COVID-19 found that mortality at 28 days in the treatment arm was half the rate seen in the control arm (12.6% vs. 24.6%), although treatment was not associated with other improvements in clinical status.
